Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Squamous Cell Carcinoma of the Nasopharynx”

187 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 187 results

Testing effectiveness (Phase 2)Study completedNCT00004865
What this trial is testing

Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy

Who this might be right for
Head and Neck Cancer
Jonsson Comprehensive Cancer Center
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Early research (Phase 1)Ended earlyNCT00023790
What this trial is testing

Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin

Who this might be right for
Breast CancerHead and Neck CancerLymphoma+3 more
Case Comprehensive Cancer Center 3
Not applicableStudy completedNCT00896896
What this trial is testing

Immunoreactivity to Cetuximab in Cancer Patients

Who this might be right for
Colorectal CancerHead and Neck Cancer
Vanderbilt-Ingram Cancer Center 538
Testing effectiveness (Phase 2)Study completedNCT00639769
What this trial is testing

Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 41
Early research (Phase 1)Study completedNCT00404339
What this trial is testing

Vaccine Therapy in Treating Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Robert Ferris 17
Large-scale testing (Phase 3)Study completedNCT00002476
What this trial is testing

Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Cancer Research UK
Not applicableStudy completedNCT01194635
What this trial is testing

Biomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cell Cancer of the Head and Neck Previously Treated With Cetuximab, Cisplatin, and Radiation Therapy

Who this might be right for
Head and Neck Cancer
ECOG-ACRIN Cancer Research Group 69
Testing effectiveness (Phase 2)Study completedNCT00003582
What this trial is testing

Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer

Who this might be right for
Carcinoma of Unknown PrimaryHead and Neck Cancer
University of Miami 36
Not applicableLooking for participantsNCT00898638
What this trial is testing

Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants

Who this might be right for
Head and Neck Cancer
Vanderbilt University Medical Center 8,000
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Early research (Phase 1)Study completedNCT00019110
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

Who this might be right for
Anal CancerCervical CancerEsophageal Cancer+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00024089
What this trial is testing

Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00458978
What this trial is testing

Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer

Who this might be right for
Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+20 more
National Cancer Institute (NCI) 6
Early research (Phase 1)Study completedNCT01064921
What this trial is testing

Ph I Vorinostat in the Treatment of Advanced Staged Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Stage III Squamous Cell Carcinoma of the OropharynxStage IV Squamous Cell Carcinoma of the Oropharynx
Ohio State University Comprehensive Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT00052429
What this trial is testing

High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer

Who this might be right for
Head and Neck Cancer
Memorial Sloan Kettering Cancer Center 25
Large-scale testing (Phase 3)Study completedNCT00274937
What this trial is testing

Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer

Who this might be right for
Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7Stage I Nasopharyngeal Undifferentiated Carcinoma AJCC v7Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7+5 more
Children's Oncology Group 111
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT02538510
What this trial is testing

Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery

Who this might be right for
Head and Neck Squamous Cell CarcinomaRecurrent Nasal Cavity and Paranasal Sinus Squamous Cell CarcinomaRecurrent Nasopharynx Carcinoma+12 more
University of Washington 50
Early research (Phase 1)Study completedNCT00004246
What this trial is testing

Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx

Who this might be right for
Head and Neck Cancer
M.D. Anderson Cancer Center 16
Next Page